GF
NKGNW

Gabelli Funds’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Gabelli Funds’s Portfolio NKGNW Stock Details NKGNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,221
Closed -$1.72K – 1123
2024
Q4 		$1.72K Hold
17,221
– – ﹤0.01% 1085
2024
Q3 		$1.22K Hold
17,221
– – ﹤0.01% 1087
2024
Q2 		$1.5K Hold
17,221
– – ﹤0.01% 1087
2024
Q1 		$2.75K Hold
17,221
– – ﹤0.01% 1083
2023
Q4 		$1.39K Buy
+17,221
New +$2.32K ﹤0.01% 1096
2023
Q3 		– Sell
-17,221
Closed -$3.44K – 1158
2023
Q2 		$3.44K Hold
17,221
– – ﹤0.01% 1104
2023
Q1 		$2.41K Sell
17,221
-2,858
-14% -$407 ﹤0.01% 1137
2022
Q4 		$1.71K Sell
20,079
-40,000
-67% -$3.36K ﹤0.01% 1185
2022
Q3 		$9K Buy
60,079
+40,000
+199% +$6.88K ﹤0.01% 1255
2022
Q2 		$5K Hold
20,079
– – ﹤0.01% 1331
2022
Q1 		$12K Hold
20,079
– – ﹤0.01% 1365
2021
Q4 		$23K Hold
20,079
– – ﹤0.01% 1373
2021
Q3 		$23K Buy
+20,079
New +$25.1K ﹤0.01% 1347

Other funds holding NKGNW

RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Gabelli Funds's NKGNW Position: Q1 2025 in Review

Gabelli Funds sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 17,221 shares — an estimated $1.72K sold.

Gabelli Funds first reported a position in NKGNW in Q3 2021 and held it in 13 quarters. The position peaked at $23K in Q4 2021. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

  • Gabelli Funds reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
  • Gabelli Funds sold 17,221 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $1.72K.
  • Gabelli Funds first reported a position in NKGen Biotech, Inc. Warrants in Q3 2021 and held it in 13 quarters.
  • Gabelli Funds's NKGen Biotech, Inc. Warrants position peaked at $23K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Gabelli Funds's 13F filing for Q1 2025, filed 14 May 2025.